KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Liabilities and Shareholders Equity (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Liabilities and Shareholders Equity data on record, last reported at $23.1 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 8.08% year-over-year to $23.1 billion; the TTM value through Dec 2025 reached $91.6 billion, up 6.47%, while the annual FY2025 figure was $23.1 billion, 8.08% up from the prior year.
  • Liabilities and Shareholders Equity reached $23.1 billion in Q4 2025 per ZBH's latest filing, down from $23.5 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $24.2 billion in Q2 2021 and bottomed at $21.1 billion in Q4 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $22.2 billion, with a median of $21.6 billion recorded in 2022.
  • Peak YoY movement for Liabilities and Shareholders Equity: fell 11.44% in 2022, then rose 8.14% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $23.5 billion in 2021, then decreased by 10.19% to $21.1 billion in 2022, then increased by 2.05% to $21.5 billion in 2023, then decreased by 0.61% to $21.4 billion in 2024, then grew by 8.08% to $23.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $23.1 billion in Q4 2025, $23.5 billion in Q3 2025, and $22.9 billion in Q2 2025.